The survival of HER2 positive screen detected breast cancers in the abscence of chemotherapy and herceptin.

被引：0
|
作者：
Johnson, R. L. [1 ]
Prasad, R. [1 ]
Knox, W. F. [1 ]
Byrne, G. [1 ]
Morris, J. [1 ]
Cramer, A. [1 ]
Wilson, A. [1 ]
Bundred, N. J. [1 ]
机构：
[1] Univ S Manchester Hosp, Manchester M20 8LR, Lancs, England
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S110 / S111
页数：2
相关论文
共 50 条
  • [21] HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers
    Wang, Tonghui
    Xu, Ye
    Sheng, Shuyan
    Yuan, Hua
    Ouyang, Tao
    Li, Jinfeng
    Wang, Tianfeng
    Fan, Zhaoqing
    Fan, Tie
    Lin, Benyao
    Xie, Yuntao
    CANCER SCIENCE, 2017, 108 (04): : 671 - 677
  • [22] Estrogen and progesterone hormone receptor status in HER2 positive breast cancers
    Kubelka-Sabit, K.
    Filipovski, V.
    Karagjozov, M.
    Stojcevska-Capova, M.
    Jasar, D.
    VIRCHOWS ARCHIV, 2015, 467 : S65 - S65
  • [23] Radiolabelled trastuzumab Fab as a theranostic molecule for HER2 positive breast cancers
    Rathore, Y.
    Shukla, J.
    Mittal, B. R.
    Singh, G.
    Gopal, K.
    Kumar, R.
    Bal, A.
    Laroiya, I.
    Lakhanpal, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S55 - S56
  • [24] HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer
    Hosonaga, Mari
    Arima, Yoshimi
    Sampetrean, Oltea
    Komura, Daisuke
    Koya, Ikuko
    Sasaki, Takashi
    Sato, Eiichi
    Okano, Hideyuki
    Kudoh, Jun
    Ishikawa, Shumpei
    Saya, Hideyuki
    Ishikawa, Takashi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [25] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    MODERN PATHOLOGY, 2018, 31 : 54 - 54
  • [26] Correlation of HER2 Immunohistochemical Scores and HER2 mRNA, Oncotype Recurrence Score and Magee Scores on ER Positive, HER2 Negative Breast Cancers
    Tyburski, Haley
    Karakas, Cansu
    Zhang, Huina
    Liu, Elena
    Turner, Bradley
    Hicks, David
    LABORATORY INVESTIGATION, 2023, 103 (03) : S216 - S217
  • [27] Herceptin - For metastatic breast cancer tumors that overexpress the HER2 protein
    不详
    FORMULARY, 1998, 33 (11) : 1046 - 1047
  • [28] Methodology Used to Determine HER2 Status Correlates with Response to Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer
    Cheng, Esther
    McIntire, Patrick
    D'Alfonso, Timothy
    Ginter, Paula
    LABORATORY INVESTIGATION, 2018, 98 : 54 - 54
  • [29] Her2-positive breast cancer: Herceptin and beyond
    Dean-Colomb, Windy
    Esteva, Francisco J.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (18) : 2806 - 2812
  • [30] Trastuzumab (herceptin) and HER2-positive breast cancer
    Murray, S
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (01) : 36 - 37
12345